News FDA probes blood cancer immunotherapy safety Regulator reviewing combination therapy safety after issue with Keytruda
News AZ tried to buy Daiichi Sankyo last year - report Trading in shares of Daiichi Sankyo was suspended yesterday.
News AZ to develop Parkinson's drug with Takeda AstraZeneca could receive up to $400 million from Takeda after approaching the company to jointly develop and market a new treatment for Parkinson’s disease (PD).
News Samsung Bioepis signs R&D agreement with Takeda South Korean firm looking to develop novel drugs
News Novo's semaglutide outperforms Lilly GLP-1 rival If approved semaglutide could become set the standard for GLP-1 therapy
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
